By Aaron Hochman-Zimmerman
New York, Sept. 22 - Elbit Medical Imaging Ltd. priced two tranches (Maalot: A+) totaling NIS 350 million, according to a press release.
The sale consisted of a tranche of series E notes with a maximum interest rate of 6.5% and a tranche of series F notes with a maximum interest rate of 5.9%.
Interest payments on the Regulation S deal will be tied to the Israeli consumer price index.
The Tel Aviv, Israel-based firm primarily deals in the development of commercial centers, hotel and property management in central and eastern Europe and also makes MRI and ultrasound equipment.
| Issuer: | Elbit Medical Imaging Ltd.
|
| Amount: | NIS 350 million
|
| Issue: | Series E tranche, Series F tranche
|
| Coupon: | Series E 6.5%, Series F 5.9% (Israel CPI-linked)
|
| Pricing date: | Sept. 21
|
| Rating: | Maalot: A+
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
